"Your body's full of veins, isn't it? Well, you've got to fill them up with something, haven't you?" That's the mystery of blood, as explained by British comedian Tony Hancock in one of the UK's best-known comedy episodes, ...
Jun 16, 2021
0
3
(HealthDay)—In new joint guidelines issued by bone health experts, recommendations are presented for managing osteoporosis therapy in the context of COVID-19 vaccination.
Mar 29, 2021
0
13
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy ...
Jul 15, 2020
0
314
For much of the 20th century, summer was considered "polio season," and people were accustomed to seeing swimming pools and movie theaters closed to stave off the latest epidemic. Shaking hands was off limits, and even touching ...
May 13, 2020
0
37
Nanoengineers at the University of California San Diego are working on a COVID-19 vaccine using an unconventional candidate: a plant virus.
Apr 21, 2020
0
0
Vaccinations are the world's frontline defence against infectious diseases yet despite decades of interventions, unsafe injection practices continue to expose billions of people to serious infection and disease.
Mar 5, 2019
0
2
Infections by the mosquito-borne Mayaro virus (MAYV) have largely been restricted to people who ventured into the heavily forested areas of Trinidad and Tobago and neighboring regions of South America. However, recent laboratory ...
Feb 7, 2019
0
27
Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study from a large European ...
Apr 26, 2017
0
0
A groundbreaking study released today shows that a single injectable dose of inactivated polio vaccine (IPV) along with bivalent oral polio vaccine could protect up to 90 percent of children from polio and strengthen community ...
May 20, 2016
0
0
(HealthDay)—U.S. Food and Drug Administration approval for the BioThrax anthrax vaccine has been expanded to include adults aged 18 to 65 with known or suspected exposure, the agency said in a media release.
Nov 24, 2015
0
2
